Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study. (2022) - Huang, X.; Xu, L.; Huang, Z.; Ni, Y.; Wang, C.; Bi, X.; Che, X.